当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析 - 现金流量表

和邦生物

(603077)

  

流通市值:126.29亿  总市值:126.29亿
流通股本:88.31亿   总股本:88.31亿

现金流量表

按照会计年度查询:
报告期2020-06-302020-03-312019-12-312019-06-30
一、经营活动产生的现金流量
销售商品、提供劳务收到的现金1,335,036,263.93678,485,003.773,402,548,588.611,693,479,206.06
收到的税费返还1,596,586.87--4,525,631.862,396,793.19
收到其他与经营活动有关的现金18,072,433.922,745,251.9415,096,644.6412,638,269.58
经营活动现金流入小计1,354,705,284.72681,230,255.713,422,170,865.111,708,514,268.83
购买商品、接受劳务支付的现金1,117,733,523.63625,124,335.292,385,503,775.981,327,967,464.01
支付给职工以及为职工支付的现金159,336,453.3389,021,793.1297,231,110.67145,062,005.95
支付的各项税费87,430,049.9235,302,809.32249,513,496.7991,750,151.76
支付其他与经营活动有关的现金112,521,403.0963,454,954.13327,001,997.16115,739,581.46
经营活动现金流出小计1,477,021,429.97812,903,891.843,259,250,380.61,680,519,203.18
经营活动产生的现金流量净额-122,316,145.25-131,673,636.13162,920,484.5127,995,065.65
二、投资活动产生的现金流量
收回投资收到的现金304,752,189.595,647,195277,507,107.73186,352,816.97
取得投资收益收到的现金39,708,383.3524,500,0002,966,477.34621,381.21
处置固定资产、无形资产和其他长期
资产收回的现金净额
828,005.31826,316.69830,526.5530,016.2
处置子公司及其他营业单位收到的现金净额--------
收到其他与投资活动有关的现金----82,001,02582,001,025
投资活动现金流入小计345,288,578.16120,973,511.69363,305,136.57269,505,239.38
购建固定资产、无形资产和其他长期资产支付的现金95,126,388.6599,846,615.97662,543,797.18172,866,859.94
投资支付的现金72,780,16572,232,650332,810,833198,858,000
取得子公司及其他营业单位支付的现金净额----643,924,976.31643,924,976.31
支付其他与投资活动有关的现金----403,82480,000
投资活动现金流出小计167,906,553.65172,079,265.971,639,683,430.491,015,729,836.25
投资活动产生的现金流量净额177,382,024.51-51,105,754.28-1,276,378,293.92-746,224,596.87
三、筹资活动产生的现金流量
吸收投资收到的现金--------
子公司吸收少数股东投资收到的现金--------
取得借款收到的现金940,843,828400,000,0001,742,776,350403,732,800
收到其他与筹资活动有关的现金----13,877,838.925,071,195.51
发行债券收到的现金--------
筹资活动现金流入小计940,843,828400,000,0001,756,654,188.92408,803,995.51
偿还债务支付的现金684,240,000200,000,0001,064,930,000166,000,000
分配股利、利润或偿付利息支付的现金46,797,210.6821,088,873.5671,101,541.3129,954,767.11
子公司支付给少数股东的股利--------
支付其他与筹资活动有关的现金100,071,735.04--253,558,029.92250,000,167.92
筹资活动现金流出小计831,108,945.72221,088,873.561,389,589,571.23445,954,935.03
筹资活动产生的现金流量净额109,734,882.28178,911,126.44367,064,617.69-37,150,939.52
四、现金及现金等价物净增加额
汇率变动对现金的影响50,893,659.0834,395,401.259,293,483.72-2,879,491.28
现金及现金等价物净增加额215,694,420.6230,527,137.28-737,099,708-758,259,962.02
期初现金及现金等价物余额573,533,869.48573,533,869.481,310,633,577.481,310,633,577.48
期末现金及现金等价物余额789,228,290.1604,061,006.76573,533,869.48552,373,615.46
补充资料:
1、将净利润调节为经营活动的现金流量:
净利润17,141,314.22--506,610,768.81290,138,776.17
加:资产减值准备-5,979,339.11--20,513,728.825,770,976.83
固定资产折旧、油气资产折耗、生产性生物资产折旧316,858,532.2--589,965,069.4273,165,587.54
无形资产摊销21,919,771.75--45,631,234.5421,287,182.83
长期待摊费用摊销606,911.82--1,033,813.73426,901.91
待摊费用减少--------
预提费用增加--------
处置固定资产、无形资产和其他长期资产的损失44,008.14--2,415,460.01288,079.77
固定资产报废损失--------
公允价值变动损失--------
财务费用37,103,182.69--59,797,386.8820,219,134.94
投资损失-21,876,544.3--1,234,072.871,169,175.72
递延所得税资产减少-11,323,965.04--1,616,752.645,363,933.23
递延所得税负债增加-576,598.22--58,486.951,475,497.42
存货的减少25,140,473.82---269,207,023.35-105,246,755.53
经营性应收项目的减少-323,717,020.58---305,911,535.04-566,753,165.25
经营性应付项目的增加-171,634,951.34---490,837,731.7580,689,740.07
未确认的投资损失--------
其他--------
经营活动产生的现金流量净额-122,316,145.25--162,920,484.5127,995,065.65
2、债务转为资本--------
3、一年内到期的可转换公司债券--------
4、融资租入固定资产--------
5、现金及现金等价物净增加情况:
现金的期末余额789,228,290.1--573,533,869.48552,373,615.46
减:现金的期初余额573,533,869.48--1,310,633,577.481,310,633,577.48
现金等价物的期末余额--------
减:现金等价物的期初余额--------
现金及现金等价物净增加额215,694,420.62---737,099,708-758,259,962.02
TOP↑